CalciMedica
CALC
20 hedge funds and large institutions have $14.8M invested in CalciMedica in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
900% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 1
894% more capital invested
Capital invested by funds: $1.49M → $14.8M (+$13.3M)
82% more funds holding
Funds holding: 11 → 20 (+9)
4.79% more ownership
Funds ownership: 1.82% → 6.61% (+4.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$4.57M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.58M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.39M |
| 4 |
ACM
Aisling Capital Management
New York
|
+$2.38M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$343K |
Top Sellers
CALC Hedge Fund Activity: Q1 2024 in Review
20 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q1 2024, worth a combined $14.8M — up 894% from $1.49M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new CALC positions and 1 closed out — a net gain of 9 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $4.57M.
- 20 institutional investors held CalciMedica (CALC) as of Q1 2024, up from 11 in Q4 2023.
- Funds reported $14.8M of CalciMedica stock for Q1 2024, up 894% quarter-over-quarter.
- 10 funds opened new CalciMedica positions in Q1 2024 and 1 closed out, a net change of +9 holders.
- The largest CalciMedica buyer in Q1 2024 was Deerfield Management, an estimated $4.57M added.
Based on aggregated 13F filings for Q1 2024.